Moderna (MRNA) PT Lowered to $69 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff lowered the price target on Moderna (NASDAQ: MRNA) to $69.00 (from $115.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
